14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 459 days ( -129.50 % )
Last Price $224.91 0 %
High/ Low $224.91 - $224.91 0%
Chg 7 Days N/A $224.91 $224.91
Chg 30 Days N/A $224.91 $224.91
Chg 12 mos N/A $224.91 $224.91
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos N/A Width: 0 %
Pred. range - 3 mos $224.91 - $224.91 0 % - 0 %
Pred. range - 12 mos N/A - N/A -100.00 % - -100.00 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Nov 30, -1 - N/A days
Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy May 26, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About MyoKardia

MyoKardia MyoKardia, Inc., a clinical stage biopharmaceutical company, engages in discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). The company also develops DCM-1, a drug compound ... MYOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT